RA Capital Management »

Belite Bio shares owned by RA Capital Management

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by RA Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $65M 875k 74.00

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Rhythm Pharmaceuticals SH (RYTM)
Vaxcyte SH (PCVX)
Avidity Biosciences SH (RNA)
Cidara Therapeutics SH (CDTX)
Sionna Therapeutics SH (SION)
89bio SH (ETNB)
Newamsterdam Pharma Co Nv SH (NAMS)
Mineralys Therapeutics SH (MLYS)
Janux Therapeutics SH (JANX)
Arcellx SH (ACLX)
Lenz Therapeutics SH (LENZ)
Tyra Biosciences SH (TYRA)
Edgewise Therapeutics SH (EWTX)
Wave Life Sciences SH (WVE)

View all positions for RA Capital Management

Top funds holding Belite Bio

RA Capital Management
Rtw Investments
Vestal Point Capital
Soleus Capital Management
Eventide Asset Management
Marshall Wace
Perceptive Advisors
Millennium Management
Geode Capital Management
State Street Corporation
Bnp Paribas Arbitrage, Snc
UBS Group
Citadel Advisors
Jpmorgan Chase & Co
Polymer Capital Management

View all funds holding Belite Bio